DIFFUSE MIDLINE GLIOMA, H3 K27-ALTERED
Clinical trials for DIFFUSE MIDLINE GLIOMA, H3 K27-ALTERED explained in plain language.
Never miss a new study
Get alerted when new DIFFUSE MIDLINE GLIOMA, H3 K27-ALTERED trials appear
Sign up with your email to follow new studies for DIFFUSE MIDLINE GLIOMA, H3 K27-ALTERED, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Sound waves could open Brain's barrier to fight deadly tumor
Disease control Not yet recruitingThis study tests a new way to treat a rare and aggressive brain tumor called diffuse midline glioma (DMG) in the brainstem. The approach uses MRI-guided focused ultrasound to temporarily open the blood-brain barrier, allowing more of the chemotherapy drug temozolomide to reach th…
Matched conditions: DIFFUSE MIDLINE GLIOMA, H3 K27-ALTERED
Phase: PHASE1, PHASE2 • Sponsor: UMC Utrecht • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Nasal spray could deliver brain tumor treatment directly to Kids' tumors
Disease control Not yet recruitingThis early-phase trial tests a nasal spray called NEO100 (a purified natural compound) in 12 children with certain aggressive brain tumors. The goal is to see if it's safe, find the best dose, and check if the drug reaches the tumor. Participants will receive increasing doses, an…
Matched conditions: DIFFUSE MIDLINE GLIOMA, H3 K27-ALTERED
Phase: PHASE1 • Sponsor: Neonc Technologies, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC